Clinical trial
Middle Meningeal Artery Embolization for Treatment of Chronic Migraine: A Pilot Study
NCT07044648 is registered in ClinicalTrials.gov with Wake Forest University Health Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Middle Meningeal Artery Embolization for Treatment of Chronic Migraine: A Pilot Study
- Lead sponsor
- Wake Forest University Health Sciences
- Phase
- Not applicable
- Overall status
- Withdrawn
- Start date
- February 28, 2026
- Completion date
- August 31, 2027
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
migraine